CuResponse For Profit
Curesponse has developed a 3-dimensional tissue culture system for modeling cancer growth and drug response. The platform, preserves the cancer tissue architecture (including vasculature and immune system) accurately reflecting the cancer growth found in the body
Founded Date:
2018-01-01
Headquarters:
Tel Aviv-yafo, Tel Aviv, Israel
Technology:
Biomarker panels
Employee Number:
11-50
Industry:
Clinical Data Management
Estimated Revenue:
$2.8Mper year
Funding Status:
Early Stage Venture